Global Infertility Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global infertility market is categorized by technology, including IVF, artificial insemination, surrogacy, and other methods. IVF remains the most widely utilized and advanced technology for treating infertility, offering solutions for couples facing various fertility challenges. Artificial insemination, which includes techniques like intrauterine insemination (IUI), is another common method, often used in cases of mild male infertility or unexplained infertility. Surrogacy, though more complex and costly, is also a growing segment, especially as awareness and legal frameworks around gestational surrogacy evolve. Other infertility technologies, such as egg freezing and fertility preservation, are seeing increasing demand due to growing societal acceptance and advancements in reproductive medicine.

Fertility drugs are also a significant segment in the market, with gonadotropins and anti-estrogens being the most commonly used types. Gonadotropins, which stimulate the ovaries to produce eggs, are used in conjunction with IVF and artificial insemination procedures. Anti-estrogen drugs, primarily used to induce ovulation, play a key role in helping women with conditions like polycystic ovary syndrome (PCOS) conceive. The growing awareness and accessibility of fertility drugs have contributed significantly to the market’s expansion, particularly as more individuals seek to delay parenthood or overcome infertility challenges later in life.

The end-user segment consists of fertility clinics, hospitals, and clinical research institutes. Fertility clinics are the primary service providers for individuals and couples seeking assisted reproductive technologies. Hospitals also contribute to the market by offering specialized services in IVF and fertility treatments. Clinical research institutes play a crucial role in advancing infertility treatments by developing new technologies and conducting trials to improve success rates. Geographically, the infertility market is growing across all regions, with North America and Europe being dominant players due to well-established healthcare infrastructure and increasing adoption of fertility treatments. Meanwhile, Asia Pacific, the Middle East, and Latin America are emerging markets with growing demand for fertility services as awareness and affordability increase.

Global Infertility Segment Analysis

In this report, the Global Infertility Market has been segmented by Technology, Fertility Drugs, and Geography.

Global Infertility Market, Segmentation by Fertility Drugs

The Global Infertility Market has been segmented by Fertility Drugs into Gonadotropin, Anti-estrogen, and Others.

Gonadotropins are one of the most widely used fertility drugs, as they stimulate the ovaries to produce eggs, often in women who have difficulty ovulating. These drugs are used in conjunction with assisted reproductive technologies like IVF or intrauterine insemination (IUI), helping increase the number of eggs available for fertilization and improving the likelihood of pregnancy. Gonadotropins have shown to be particularly beneficial for women with conditions such as polycystic ovary syndrome (PCOS), where ovulation is irregular or absent.

Anti-estrogen drugs are another common category of fertility medications, commonly used to treat women with ovulation disorders. These drugs work by blocking the effects of estrogen, thus stimulating the pituitary gland to release more follicle-stimulating hormone (FSH), which encourages the ovaries to release eggs. Clomiphene citrate is one of the most well-known anti-estrogen medications, and it is often used in less complex cases of infertility, offering a less invasive and more affordable option compared to advanced reproductive technologies. These medications are typically prescribed to women who have difficulty ovulating on their own but have otherwise healthy reproductive systems.

Other fertility drugs include progesterone supplements, which are often prescribed after ovulation to support the early stages of pregnancy, and aromatase inhibitors, which are used to treat women who do not respond to other fertility medications. The demand for these fertility drugs is closely tied to the growing number of individuals seeking infertility treatments. As awareness increases and new drug formulations are introduced, fertility drugs continue to be a major component in the comprehensive treatment options available to those struggling with infertility. These drugs are often used in combination with various reproductive technologies to increase the chances of successful conception.

Global Infertility Market, Segmentation by End user

The Global Infertility Market has been segmented by End user into Fertility Clinics, Hospitals, and Clinical Research Institutes.

Fertility clinics are one of the largest and most specialized segments within the infertility treatment sector. These clinics focus exclusively on assisting individuals and couples with fertility issues. They provide a wide range of services, including in vitro fertilization (IVF), artificial insemination, and other assisted reproductive technologies (ART). With their expertise, fertility clinics offer personalized care, helping patients navigate complex infertility challenges, and often serve as a primary point of care for individuals seeking reproductive assistance. The increasing prevalence of infertility, coupled with advancements in fertility treatments, drives the demand for services provided by fertility clinics.

Hospitals also play a crucial role in the infertility treatment market, particularly for patients requiring more comprehensive care or facing complex infertility issues. Many hospitals have dedicated departments for reproductive medicine, offering advanced diagnostic services and a range of fertility treatments, including surgeries for conditions like endometriosis or blocked fallopian tubes. Hospitals tend to cater to a broader patient demographic and provide more extensive facilities compared to specialized fertility clinics. They may be especially sought after by individuals who require additional medical support during their fertility treatments, such as those with underlying health conditions or who are undergoing high-risk pregnancies. The integration of infertility treatment within hospital settings makes these services accessible to a larger segment of the population.

Clinical research institutes contribute to the growth of the infertility market by driving innovation and expanding the range of treatment options available. These institutes focus on studying new fertility treatments, conducting clinical trials, and advancing the understanding of infertility causes and treatments. The research done in these institutes often leads to the development of improved fertility medications, advanced diagnostic tools, and novel ART procedures. As they partner with fertility clinics and hospitals, clinical research institutes play a critical role in enhancing the effectiveness and safety of infertility treatments, fostering new breakthroughs in the field. Their contributions are essential to improving patient outcomes and expanding the global access to infertility treatments.

Global Infertility Market, Segmentation by Geography

In this report, the Global Infertility Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Infertility Market Share (%), by Geographical Region, 2024

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America serving as significant markets. North America and Europe lead the market owing to their advanced healthcare infrastructure, heightened awareness levels, and supportive governmental regulations. These regions benefit from the presence of leading pharmaceutical and medical device firms, fostering innovation and adoption of state-of-the-art infertility therapies. Additionally, lifestyle factors such as delayed family planning and environmental stressors contribute to a higher demand for infertility solutions in these areas.

The infertility market in Asia Pacific is rapidly expanding due to factors like rising disposable incomes, evolving lifestyles, and improving healthcare facilities. Countries like China and India, with their sizable populations, witness a surge in infertility cases, driving the need for infertility medications and technologies. Furthermore, increasing acceptance of assisted reproductive techniques (ART) and escalating healthcare investments propel market growth in the region. Nevertheless, regulatory intricacies and cultural perceptions surrounding infertility treatment may pose challenges to market expansion.

In the Middle East and Africa, as well as Latin America, the infertility market emerges as a promising sector. These regions encounter unique obstacles, including limited healthcare access, socioeconomic inequalities, and cultural taboos associated with infertility. Despite these challenges, escalating healthcare spending, heightened awareness, and concerted efforts to address reproductive health issues fuel market development. Collaborative endeavors between international healthcare entities and local stakeholders play a pivotal role in expanding access to infertility therapies and support services, thereby unlocking the untapped market potential in these regions.

This report provides an in depth analysis of various factors that impact the dynamics of Global Infertility Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Key players in Global Infertility Market include:

• Bayer HealthCare
• CooperSurgical
• Ferring Pharmaceuticals
• Merck & Co. Inc.
• Actavis

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis